AGA Medical Holdings, Inc.
AGA Medical Wins Injunction Against Occlutech's Figulla Flex
Published in Physician Law Weekly, November 18th, 2009
AGA Medical Holdings, Inc. (AGA Medical) (NASDAQ:AGAM) announced that the German Regional Court in Dusseldorf, Germany has granted a preliminary injunction against the manufacture, possession and sale of the Figulla® Flex occluders manufactured by Occlutech GmbH in Jena, Germany. The judge determined that the Figulla® Flex occluders infringe AGA Medical's patent EP 0 808 138 in Germany. On October 29, a bailiff was sent to Occlutech's facility in Jena and seized over 2,700 infringing devices.
As a result of this decision and the prior decisions of the German courts, Occlutech GmbH is now prevented from selling any of its occlusion products in Germany or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2009-11-18)
More Articles from Physician Law Weekly
- AIDS Healthcare Foundation
Obama Lifts US Travel Ban on HIV-infected; Updated AIDS Bill Puts New Focus on Testing - Allied World Assurance Company Holdings, Ltd
Allied World's Paul DeGiulio to Particpate in Discussion Group at the Network of Trial Law Firms' 2009 Litigation Management Supercourse - Alzheimer Disease
ANAVEX completes scale-up manufacturing of ANAVEX 2-73 for Phase I Alzheimers disease clinical trials - Alzheimer Disease
Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease: New 12-Month Study Broadens Phase 3 Clinical Program To Further Evaluate the Benefits of Dimebon In Alzheimers Disease - American College of Surgeons
Twenty Surgical Groups Say Senate Health Legislation Will Threaten Patient Access and Harm Quality - American Humane Association
American Humane Testifies for Reauthorization & Expansion of Child Abuse Prevention and Treatment Act, Plus Increased Use of 'Differential Response' and Other Approaches - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
